Pharmaxis Ltd (AU:SNT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Syntara Limited, an ASX-listed company, has attributed recent trading activity in its securities to investor anticipation of upcoming interim trial data on its SNT-5055 drug, as well as increased coverage by a major broker. The company plans to release the data after peer review at a scientific meeting and maintains that the information remains confidential. Despite market fluctuations, Syntara confirms its compliance with ASX listing rules.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
